|
Reviewed by Dr Patricia Macnair, GP
|
|||||
What is asthma?
There seems to be an increase in the amount of asthma all over the world, especially in children. To understand what happens in asthmatic attacks, it's helpful to visualise the basic structure of the airway tubes of the lung. The main airway (windpipe, trachea) of the body is about 2 to 3cm across. It divides into its main branches (bronchi), which lead to the right and left lung, which divide further, like the branches of a tree, to supply air to all parts of the lungs. The smallest tubes (bronchioles) are only millimetres wide and they are made up of ring-shaped muscles that are capable of contracting or relaxing. Anything that makes them contract will narrow the passages, which makes it more difficult for the air to pass through (so making it harder to breathe) and also gives rise to the characteristic wheezy noise that a person makes when they have an asthma attack. Asthmatics tend to be sensitive to various types of irritants in the atmosphere that can trigger this contraction response from the bronchial muscles. The bronchioles also have an inner lining that becomes inflamed in asthma, which makes the lining swell and produce an excess amount of the mucus (phlegm) it normally makes, clogging up the tubes. All of these processes contribute to the airway narrowing and the treatment for asthma is aimed at reversing them as much as possible. People of all ages get asthma but 50 per cent of sufferers are children under 10. Asthma is slightly more common among boys than girls. But after puberty the pattern reverses and among adults, women are more likely to develop asthma than men. Over 5 million people in the UK are currently receiving treatment for asthma, with it costing the NHS £1,000 million per year (stats from Asthma UK). How do you get asthma? Asthma can be triggered by external agents, such as irritants in the atmosphere which are breathed in, or by internal reactions within the body that have been caused by an external influence. The kinds of provoking factors can be divided into two groups.
A mother who smokes, low birth weight, a lack of exposure to infection in early life and traffic fumes have all been associated with the increase in asthma. Less draughty houses resulting in an accumulation of house dust mites and cooking gases may also be part of the problem. Currently, a great deal of research is being carried out to look for the genes that allow asthma to develop. But until we can prevent asthma, the aim of treatment is to suppress the symptoms and try to avoid the triggers where possible. What might trigger acute asthma attacks?
What are the danger signals of severe attacks requiring immediate medical attention?
The diagnosis is made on the basis of the patient's history of symptoms and on simple tests of the lungs' function. But it's not always easy to come to a diagnosis of asthma if the symptoms are mild and intermittent. For those people whose asthma is associated with eczema and hay fever it can be helpful to take blood samples and skin tests to look for hypersensitivity towards specific substances. Can I safely exercise? Be active. If you get attacks during intense activity it may be a good idea to take 'reliever' medicine before you begin to exercise. These medicines, properly known as bronchodilators, have a relaxing effect on the muscle surrounding the bronchioles. Swimming is probably the best form of exercise for asthma patients but the most important thing is to stay active. What are the prospects for asthma suffers?
Medicines for asthma are generally thought of in two main groups.
There are many different drugs used as asthma relievers, and they fall into three groups.
Beta-2 agonists act on molecule-sized receptors on the muscle of the bronchioles. The medicine fits the receptor like a key fits a lock and causes the muscle to relax. Examples of those which act for a short time (three or four hours following a single dose) are salbutamol (eg Ventolin) and terbutaline (eg Bricanyl). These start to work very quickly after inhalation and are used when required to relieve shortness of breath. They can also be used to open the airways before exercise. Longer-acting beta-2 agonists include salmeterol (eg Serevent) and formoterol (eg Foradil, Oxis). Their action lasts over 12 hours, making them suitable for twice-daily dosage to keep the airways open throughout the day. Formoterol works rapidly to open the airways like the short-acting beta-2 agonists. A combination inhaler called , which contains formoterol together with the corticosteroid budesonide, is licensed to be used regularly as a preventer and when needed as a reliever to relieve shortness of breath. Symbicort is only licensed for use as both preventer and reliever in adults over 18 years of age. Beta-2 agonists are inhaled from a variety of delivery devices, the most familiar being the pressurised metered-dose inhaler (MDI). Other devices include breath-actuated inhalers such as autohalers and dry powder inhalers such as turbohalers.
One of the ways in which the size of the airways is naturally controlled is through nerves that connect to the muscles. The nerve impulses cause the muscles to contract, thus narrowing the airway. Anticholinergic medicines block this effect, allowing the airways to open. The size of this effect is fairly small, so it is most noticeable if the airways have already been narrowed by other conditions, such as chronic bronchitis. An example of an anticholinergic is ipratropium bromide (eg Atrovent). It has a maximum effect 30 to 60 minutes after inhalation, which lasts for three to six hours. A longer lasting anticholinergic called tiotropium bromide need only be taken once a day and may sometimes be used in severe asthma but is slow in onset and so not for acute attacks.
Theophylline (eg Slo-phyllin) and aminophylline (eg Phyllocontin continus) are given by mouth and are less commonly used in Britain because they are more likely to produce side effects than inhaled treatment. They are still in very wide use throughout the world.
There are three main groups of these.
Corticosteroids (or 'steroids') such as beclometasone (eg Beclazone), budesonide (eg Pulmicort) and fluticasone (eg Flixotide) have made an enormous difference to the management of asthma. They work to reduce the amount of inflammation within the airways, reducing their tendency to contract and have allowed many patients with previously troublesome asthma to lead almost symptom-free lives. They are usually given as inhaled treatment, although sometimes oral steroid tablets (prednisolone, eg Deltacortril) may be required for severe attacks. Although steroids are powerful medicines with many potential side effects, their safety in asthma has been well established. It is also important to balance the problems that arise from poorly treated asthma against the improvement in health which occurs when the condition is well treated.
There are two medicines in the cromone group: sodium cromoglicate (eg Intal) and nedocromil sodium (eg Tilade). They also act to reduce inflammation of the airways. They tend to be best for mild asthma and are more effective in children than adults. The medicines are given by inhalation and are usually very well tolerated.
Leukotrienes are chemicals that are released from the lungs in people with asthma, causing inflammation and increased mucus production in the airways. They also cause the muscles lining the airways to contract, which narrows the airways. All of this makes it difficult for air to get in and out of the lungs. Leukotriene receptor antagonists block leukotriene receptors in the lungs and, as a result, block the action of the leukotrienes. This prevents the excess mucus production, inflammation and narrowing of the airways and so prevents asthma attacks. It’s also useful for preventing asthma triggered by exercise. There are two leukotriene receptor antagonists currently available: montelukast (Singulair) and zafirlukast (Accolate), both of which are taken as tablets. A new 'biological therapy' has recently been introduced for severe persistent allergic asthma. Omalizumab (Xolair) is a recombinant monoclonal antibody that prevents the release of the chemicals involved in inflammation and reduces allergen-induced airway reactions. However this treatment is only currently used in very specific cases.
Combination inhalers have been the mainstay of asthma treatment for a number of years. In the 1990s longer-acting treatments which combined bronchodilators and/or corticosteroids and delivered them together using just one device were developed. There are currently a number of these regularly used in the UK, such as Seretide (salmeterol, fluticasone), Symbicort (budesonide, formoterol) and Combivent UDVs (salbutamol, ipratropium). Many patients feel their asthma is much better controlled on these combination inhalers and they are more likely to use them effectively as they only need to use one inhaler rather than two. Easy to use, they can also be useful in visually impaired patients and those who find using two or even three inhalers difficult to remember. Some trials have found that morning peak flow rates are better using combination inhalers rather than single inhaler alone. Hay fever and allergic perennial rhinitis: why do you get hay fever? Vitamins, minerals and supplements: which vitamins do we know about? Allergy tests: listed here are the most commonly used tests in dermatology. |
|||||
| Based on a text by Dr Carl J Brandt and Dr Finn Rasmussen |
|||||
| Last updated 27.10.2011 |
|||||
![]() |
|
|
|
|
| The materials in this web site are in no way intended to replace the professional medical care, advice, diagnosis or treatment of a doctor. The web site does not have answers to all problems. Answers to specific problems may not apply to everyone. If you notice medical symptoms or feel ill, you should consult your doctor - for further information see our Terms and conditions. |
|
© Copyright 1998-2011 NetDoctor.co.uk - All rights reserved |









